The FLAMIN-GO research project, designed to develop “tailored” treatments for each patient suffering from Rheumatoid Arthritis, has now begun. Under the leadership of the University of Eastern Piedmont, the project originated from a collaboration among different public and private organizations, including the Institute of Nanotechnology of the National Research Council (Cnr Nanotec) at Lecce, Queen Mary University of London, the Max Planck Institute, and the Swiss AO Foundation.